Clinical features of limbic encephalitis with LGI1 antibody. - Wikidata - wikimedia - TriplyDB

Clinical features of limbic encephalitis with LGI1 antibody.

Clinical features of limbic encephalitis with LGI1 antibody.

http://www.wikidata.org/entity/Q33825874

about

Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.

P2860

Q55456679-DCAE0DE3-4B83-47EB-9DB6-E733655E10F9

P2860

Clinical features of limbic encephalitis with LGI1 antibody.

http://www.wikidata.org/entity/Q33825874

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Clinical features of limbic encephalitis with LGI1 antibody.

@ast

Clinical features of limbic encephalitis with LGI1 antibody.

@en

type

label

Clinical features of limbic encephalitis with LGI1 antibody.

@ast

Clinical features of limbic encephalitis with LGI1 antibody.

@en

prefLabel

Clinical features of limbic encephalitis with LGI1 antibody.

@ast

Clinical features of limbic encephalitis with LGI1 antibody.

@en

P1433

Q33825874-02C8B0C3-22AF-43D3-AC09-17DE40DF322C

P1476

Q33825874-9B336F5C-A3DB-4552-9A6A-BD7A6E657853

P2093

Q33825874-10F4DD3D-2602-41A3-8AB5-6E86390C262F

Q33825874-499A90C3-CD8A-47BB-AB8F-17FBABEBF473

Q33825874-A419172E-EB3C-4CC7-A74C-66775CD32356

Q33825874-C22698DA-2E24-44DB-B5D3-99AEF099E220

Q33825874-D7B2F6CF-19AE-4886-8838-A11F1364E0D5

P2860

Q33825874-03077437-D2E4-443B-B576-C7188FC655F8

Q33825874-0A17535D-9D91-4B82-A234-F355B0D2EFE4

Q33825874-1666CD83-051C-4A27-98FF-3247D4ED667D

Q33825874-2A5E15A6-AFAC-4D42-81C9-7C527CA5516A

Q33825874-370FF43F-D62A-4976-8FF7-11F8B9B3BBED

Q33825874-3942A415-21FD-4091-A75D-9311E0029E13

Q33825874-3EA11C26-551C-499A-BD23-14291AE5E890

Q33825874-483FEDB1-509B-4B5E-A702-F144B1969790

Q33825874-51100F09-61CF-49FD-8332-418C0BA5FA00

Q33825874-527BB7D1-9E2C-4ABC-A778-F9C32A035B56

P304

Q33825874-8911EC14-EBCD-4938-9172-1D77A38AD81E

P31

Q33825874-28CC27D7-E0B1-43C3-A196-39C655B65A46

P356

Q33825874-8CAE8472-9E25-4F41-A79A-9909AD1874FE

P407

Q33825874-5984B650-D72C-4357-89B3-898FBF3CE4B9

P478

Q33825874-EEEAB142-8AF7-45FB-AFAE-0AA480CD07B5

P50

Q33825874-BD0C85DD-BB12-41DB-84F4-A6750B7B8EEB

P577

Q33825874-336037D4-7E0F-475E-A469-D31A28C9DF06

P698

Q33825874-F0FD6088-DEC7-489B-90E2-8DF7AA645E85

P932

Q33825874-2DAABAFD-5C96-4914-8D74-A4BA48248992

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Clinical features of limbic encephalitis with LGI1 antibody.

@en

P2093

Meiling Wang

http://www.w3.org/2001/XMLSchema#string

Qingxin Liu

http://www.w3.org/2001/XMLSchema#string

Wenbin Ma

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Cao

http://www.w3.org/2001/XMLSchema#string

Xuewu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia

From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time

Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies

Potassium channel antibodies in two patients with reversible limbic encephalitis

Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.

Phenotypic variants of autoimmune peripheral nerve hyperexcitability.

Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody

P304

1589-1596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S136723

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28670128

http://www.w3.org/2001/XMLSchema#string

P932

5481279

http://www.w3.org/2001/XMLSchema#string